Tejada MÁ

No ORCID on file · 3 papers in corpus
other 2025
Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1546059
meta-analysis 2024
P2X3 and P2X2/3 receptors inhibition produces a consistent analgesic efficacy: A systematic review and meta-analysis of preclinical studies
European journal of pharmacology ·doi:10.1016/j.ejphar.2024.177052

BACKGROUND: P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate the preclinical evid…

article 2021
A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment
Biomedicines ·doi:10.3390/biomedicines9030269

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mous…